Marshall Wace North America’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$20.7M	Buy	+112,359	New	+$22.1M	0.09%	231
2021 Q2	–	Sell	-272,286	Closed	-$45.5M	–	1798
2021 Q1	$45.5M	Sell	272,286 -38,023	-12%	-$6.34M	0.19%	127
2020 Q4	$47.1M	Sell	310,309 -70,737	-19%	-$9.28M	0.21%	123
2020 Q3	$38.5M	Buy	381,046 +62,710	+20%	+$6.88M	0.25%	102
2020 Q2	$38.5M	Buy	318,336 +287,192	+922%	+$32.3M	0.25%	103
2020 Q1	$2.95M	Buy	+31,144	New	+$2.96M	0.02%	412
2019 Q3	–	Sell	-7,772	Closed	-$606K	–	1567
2019 Q2	$606K	Buy	+7,772	New	+$727K	﹤0.01%	854
2019 Q1	–	Sell	-12,327	Closed	-$1.34M	–	1917
2018 Q4	$1.34M	Buy	+12,327	New	+$1.43M	0.01%	541
2018 Q3	–	Sell	-3,154	Closed	-$357K	–	1384
2018 Q2	$357K	Buy	+3,154	New	+$347K	﹤0.01%	1147
2017 Q4	–	Sell	-31,964	Closed	-$3.74M	–	1628
2017 Q3	$3.74M	Buy	+31,964	New	+$4.08M	0.02%	630
2017 Q2	–	Sell	-70,630	Closed	-$9.54M	–	1474
2017 Q1	$9.54M	Buy	+70,630	New	+$10.7M	0.08%	282
2013 Q4	$214K	Buy	+1,891	New	+$171K	﹤0.01%	634